Patient Education
Share your love
Ray Tracing Optimization – Myopic LASIK & AI
Laser-assisted in situ keratomileusis (LASIK) has become one of the most effective and safe methods for correcting refractive error with laser corneal intervention, as evidenced by the long and large number of publications in the peer-reviewed literature. In recent years,…
EC Approves Opuviz, Eylea Biosimilar
Samsung Bioepis and Biogen have announced that the European Commission (EC) has approved Opuviz 40 mg/mL for injection. This biosimilar, also known as SB15, references the widely used treatment Eylea (aflibercept). The approval encompasses a range of retinal conditions, providing…
FDA Reviews Aldeyra’s Dry Eye Drug
Aldeyra Therapeutics has announced a major milestone as the FDA formally accepted its resubmitted New Drug Application (NDA) for reproxalap, a topical ocular therapy for the treatment of dry eye disease. Alongside this regulatory progress, Aldeyra has expanded its exclusive…
SERI and ZEISS Partner to Improve Vision Care
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec have launched a groundbreaking collaboration aimed at advancing cataract and refractive surgery outcomes. The initiative, called Ophthalmic Tech Innovation by ZEISS and SERI (OPTIZS), involves a combined investment of nearly…
Alcon’s IOL Faces Probe by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) has formed a committee to investigate allegations of quality issues with an intraocular lens (IOL) supplied by Alcon. The Swiss-American company specializes in eye care products, including lenses for cataract surgery. Specifics of…
OBN Spotlight TV: Interview with Hillary A. Golden
In late October, Medicare introduced proposed Local Coverage Determinations (LCDs) that aimed to impose restrictions on Minimally Invasive Glaucoma Surgery (MIGS) procedures. These LCDs were met with significant concern and opposition from medical professionals, patient advocacy groups, and the ophthalmology…
Innovations in Dry Eye Testing: New Diagnostic Tools
Dry eye disease (DED), also known as keratoconjunctivitis sicca, is one of the most common ophthalmic conditions, affecting hundreds of millions of people worldwide. Recent technological advances and research targeting DED have led to the emergence of new definitions and…
Cequa Shows Positive Phase 4 Results for Dry Eye
Sun Pharmaceutical has shared new Phase 4 clinical trial data, showcasing the efficacy of Cequa (cyclosporine ophthalmic solution) 0.09% in treating dry eye disease (DED). The results reveal that Cequa provides sustained improvements in patients whose symptoms were inadequately managed…
MediPrint Announces Positive Results for Glaucoma Lens
MediPrint Ophthalmics has revealed positive findings from its Phase 2b clinical trial for LL-BMT1, a 3D-printed, drug-eluting contact lens designed to treat mild to moderate glaucoma. These results, presented by Ian Ben Gaddie, OD, FAAO, at the American Academy of…
Top 15 International Ophthalmology Congresses in 2024
As the field of ophthalmology continues to advance, a plethora of international congresses offer opportunities for professionals to explore the latest innovations, share insights, and foster collaborations. Here is a comprehensive list of the top 15 international ophthalmology conferences scheduled…